Second generation instis for the treatment of HIV-1 in patients with TB CO-infection on rifampicin-based treatment in kwazulu natal, south africa

Ended Project Grant Awarded Last action

Award ID
R01AI152142
Recipient
Awarding agency
Obligated
$2,855,024

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
South Africa

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $285,787
Amendment $200,932
Amendment $290,914
Amendment $282,070
Amendment $369,940
Amendment $303,515
Amendment $129,848
Amendment $192,499
Amendment $122,912
Amendment $192,493
Amendment $137,534
Amendment $154,093
Original award $192,487
Show all 14

Quick answers

Who received award R01AI152142?

R01AI152142 was awarded to Centre For The Aids Program Of Research In South Africa by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 31, 2020.

How much is award R01AI152142 worth?

$2,855,024 has been obligated on R01AI152142.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award